# cCAM Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ccam-biotherapeutics

- Industry: Biotechnology
- Headquarters: Qiryat Shemona, Israel
- Website: www.ccam-bio.com
- Latest round: Series A (Sep 15, 2012)
- Investors on record: 4

## About

cCAM Biotherapeutics Ltd. focuses on advanced regulatory affairs consulting for the immunotherapy sector, aiding biopharmaceutical developers in navigating complex regulatory processes and enhancing patient advocacy initiatives.cCAM Biotherapeutics Ltd. specializes in regulatory affairs consulting tailored for immunotherapies. Headquartered in Qiryat Shemona, Israel, the company was acquired by Merck & Co., Inc. in July 2015 for USD 605 mn. The firm has completed 2 deals to date.CCAM Bio specializes in advanced regulatory affairs consulting services tailored for the immunotherapy sector. Their offerings include strategic guidance on regulatory processes, orphan drug designation, real-world evidence integration, and biomarker assessment, serving clients within the biopharmaceutical industry, particularly in North America and Europe.CCAM Bio's revenue model is based on consulting and advisory services for clients in immunotherapy. The company operates on a fee-for-service structure, with clients engaging for bespoke consulting projects or ongoing support involving collaborative agreements with pharmaceutical companies.Following its acquisition in July 2015, cCAM Biotherapeutics Ltd. aims to leverage recent funding from Merck to expand its regulatory consulting services. The company plans to enhance its offerings in North America and Europe by developing new products and exploring additional markets. Specific expansion dates have not been detailed.

## Funding rounds

- Series A, Sep 15, 2012 — OrbiMed Advisors, Pontifax Venture Capital, Roche Venture Fund, Arkin Holdings

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Series A
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series A
- Arkin Holdings — Series A